09/24/2026
New head-to-head PSMA PET data are coming at ASTRO 2026.
Blue Earth Diagnostics will present findings comparing flotufolastat F 18 and piflufolastat F 18 detection rates in patients with recurrent prostate cancer, along with research evaluating fluciclovine F 18 PET/CT for imaging brain metastases after surgery.
Blue Earth Diagnostics, part of the Bracco Group, will present new research on precision molecular imaging.